Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
ApartmentLove (C.APLV) Announces Agreement with Yardi (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Marizyme Inc. MRZM

Healthcare Biotechnology
Marizyme is a multi-technology biomedical company dedicated to the accelerated development & commercialization of medical device technologies that improve patient health outcomes. Marizyme seeks to leverage their healthcare innovations biomedical technologies: DuraGraft®, Krillase®, & MATLOCTM to address critical market gaps & offer transformative potential to wide range of issues including... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCQB:MRZM)

Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products

GlobeNewswire May 10, 2023

Marizyme CEO Delivers Business Update

GlobeNewswire May 3, 2023

Statera Biopharma Announces Changes to Board of Directors

GlobeNewswire February 25, 2022

Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office

GlobeNewswire January 5, 2022

Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing

GlobeNewswire December 23, 2021

Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress

GlobeNewswire December 3, 2021

Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories

GlobeNewswire December 3, 2021

Marizyme is Pleased to Announce the Appointment of David Barthel as CEO

GlobeNewswire November 16, 2021

Marizyme, Inc. Issues Letter to Shareholders

PR Newswire March 31, 2021
View More News ››

Opinion & Analysis (OTCQB:MRZM)

Revolutionizing vascular grafting with a durable solution

Brieanna McCutcheon  11 hours ago
View More Opinion ››

Bullboard Posts (OTCQB:MRZM)

Be the first to post on this bullboard.

Imagine Lithium Inc.

Imagine Lithium Inc.

Imagine Lithium is an exploration company advancing its Jackpot Lithium Project in Nipigon, Ontario. The project has a ...
View More »